Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease

Stem Cells

Volumn 26, Issue 8, 2008, Pages 2183-2192

  Murrell, Wayne ^a,e   Wetzig, Andrew ^a   Donnellan, Michael ^a   Féron, François ^b   Burne, Tom ^a,c   Meedeniya, Adrian ^a   Kesby, James ^a,c   Bianco, John ^a   Perry, Chris ^d   Silburn, Peter ^a,c   Mackay Sim, Alan ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b Mediterranée University   (France)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Autologous cell therapy; Dopaminergic; Olfactory stem cell; Parkinson's disease

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BEHAVIOR; BRAIN; CELL GROWTH; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NEURAL STEM CELL; NONHUMAN; OLFACTORY EPITHELIUM; PARKINSON DISEASE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BIOPSY; BRAIN; CELL DIFFERENTIATION; CELL LINEAGE; DOPAMINE; FEMALE; HUMANS; NEURONS; OLFACTORY MUCOSA; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

RATTUS;

EID: 55049099234     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2008-0074     Document Type: Article

References (61)

1. Young R. Update on Parkinson's disease. Am Fam Physician 1999;59:2155-2167, 2169-2170.
2. Winkler C, Kirik D, Bjorklund A. Cell transplantation in Parkinson's disease: How can we make it work?. Trends Neurosci 2005;28:86-92.
3. Sayles M, Jain M, Barker RA. The cellular repair of the brain in Parkinson's disease-Past, present and future. Transpl Immunol 2004;12:321-342.
4. Brundin P, Karlsson J, Emgard M et al. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant 2000;9:179-195.
5. Deacon T, Schumacher J, Dinsmore J et al. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997;3:350-353.
6. Hayakawa H, Hayashita-Kinoh H, Nihira T et al. The isolation of neural stem cells from the olfactory bulb of Parkinson's disease model. Neurosci Res 2007;57:393-398.
7. Murrell W, Bushell GR, Livesey J et al. Neurogenesis in adult human. Neuroreport 1996;7:1189-1194.
8. Feron F, Perry C, McGrath J et al. New techniques for biopsy and culture of human olfactory epithelial neurons. Arch Otolaryngol Head Neck Surg 1998;124:861-866.
9. Roisen FJ, Klueber KM, Lu CL et al. Adult human olfactory stem cells. Brain Res 2001;890:11-22.
10. Wolozin B, Sunderland T, Zheng BB et al. Continuous culture of neuronal cells from adult human olfactory epithelium. J Mol Neurosci 1992;3:137-146.
11. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-1710.
12. Murrell W, Féron F, Wetzig A et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005;233:496-515.
13. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand. 1971;367:69-93.
14. Murrell W, Feron F, Wetzig A et al. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005;233:496-515.
15. Fuxe K, Ungerstedt U. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: Studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour. Pharmacol Ther [Lsqb]B[Rsqb] 1976;2:41-47.
16. Calne D, Snow B, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127.
17. Raymon HK, Thode S, Zhou J et al. Immortalized human dorsal root ganglion cells differentiate into neurons with nociceptive properties. J Neurosci 1999;19:5420-5428.
18. Balasubramaniyan V, Boddeke E, Bakels R et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 2006;143:939-951.
19. Hansel DE, Eipper BA, Ronnet GV. Neuropeptide Y functions as a neuroproliferative factor. Nature 2001;410:940-944.
20. Horner C, Westwood S, Hanson G et al. Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism. J Pharmacol Exp Ther 2006;319:414-421.
21. Smidt M, Burbach P. How to make a mesodiencephalic dopaminergic neuron. Nat Neurosci 2007;8:21-32.
22. Kim JH, Auerbach JM, Rodriguez-Gomez JA et al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease. Nature 2002;418:50-56.
23. Greene LA, Shain W, Chalazonitis A et al. Neuronal properties of hybrid neuroblastoma x sympathetic ganglion cells. Proc Natl Acad Sci U S A 1975;72:4923-4927.
24. Schelkunov EL, Andreeva OG, Korovin KF et al. The functional role of the noradrenergic neurons in the thermoregulatory circuits in mice. J Neural Transm 1981;50:113-137.
25. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. New York: Academic Press, 1986.
26. Stanic D, Finkelstein D, Bourke D et al. Timecourse of striatal reinnervation following lesions of dopaminergic SNpc neurons of the rat. Eur J Neurosci Biobehav Rev 2003;18:1175-1188.
27. Greene LA, Angelastro JM. You can't go home again: Transcriptionally driven alteration of cell signaling by NGF. Neurochem Res 2005;30:1347-1352.
28. Ai Y, Markesbery W, Zhang Z et al. Intraputamenal infusion of GDNF in aged rhesus monkeys: Distribution and dopaminergic effects. J Comp Neurol 2003;461:250-261.
29. Ali SA, Pappas IS, Parnavelas JG. Collagen type IV promotes the differentiation of neuronal progenitors and inhibits astroglial differentiation in cortical cell cultures. Brain Res Dev Brain Res 1998;110:31-38.
30. Bowenkamp KE, Hoffman AF, Gerhardt GA et al. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 1995;355:479-489.
31. Huang S, Saint-Jeannet JP, Kan P et al. Extracellular matrix: An immunological and biochemical (CAT and TOH activity) survey of in vitro differentiation of isolated amphibian neuroblasts. Cell Differ Dev 1990;30:219-233.
32. Lin H, Spradling AC. Germline stem cell division and egg chamber development in transplanted Drosophila germaria. Dev Biol 1993;159:140-152.
33. Riaz SS, Theofilopoulos S, Jauniaux E et al. The differentiation potential of human foetal neuronal progenitor cells in vitro. Brain Res Dev Brain Res 2004;153:39-51.
34. Sun ZH, Lai YL, Li P et al. GDNF augments survival and differentiation of TH-positive neurons in neural progenitor cells. Cell Biol Int 2004;28:323-325.
35. Oiwa Y, Nakai K, Itakura T. Histological effects of intraputaminal infusion of glial cell line-derived neurotrophic factor in Parkinson disease model macaque monkeys. Neurol Med Chir (Tokyo) 2006;46:267-275, discussion 275-266.
36. McLeod M, Hong M, Mukhida K et al. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease. Eur J Neurosci 2006;24:361-370.
37. af Bjerken S, Boger HA, Nelson M et al. Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures. Brain Res 2007;1133:10-19.
38. Borgal L, Hong M, Sadi D et al. Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro. Neuroscience 2007;147:712-719.
39. Bjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A 2002;99:2344-2349.
40. Greene LA, Rein G. Release, storage and uptake of catecholamines by a clonal cell line of nerve growth factor (NGF) responsive pheo-chromocytoma cells. Brain Res 1977;129:247-263.
41. Takagi Y, Takahashi J, Saiki H et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 2005;115:102-109.
42. Baier PC, Schindehutte J, Thinyane K et al. Behavioral changes in unilaterally 6-hydroxy-dopamine lesioned rats after transplantation of differentiated mouse embryonic stem cells without morphological integration. STEM CELLS 2004;22:396-404.
43. Burnstein RM, Foltynie T, He X et al. Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int J Biochem Cell Biol 2004;36:702-713.
44. Harrower TP, Tyers P, Hooks Y et al. Long-term survival and integration of porcine expanded neural precursor cell grafts in a rat model of Parkinson's disease. Exp Neurol 2006;197:56-69.
45. Wang X, Lu Y, Zhang H et al. Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson's disease. Int J Dev Neurosci 2004;22:175-183.
46. Xu H, Fan X, Wu X et al. Neural precursor cells differentiated from mouse embryonic stem cells relieve symptomatic motor behavior in a rat model of Parkinson's disease. Biochem Biophys Res Commun 2005;326:115-122.
47. Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004;113:1701-1710.
48. Pavon-Fuentes N, Blanco-Lezcano L, Martinez-Martin L et al. Stromal cell transplant in the 6-OHDA lesion model. Rev Neurol 2004;39:326-334.
49. Johansson S, Lee IH, Olson L et al. Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions. Brain 2005;128:2961-2976.
50. Nishimura F, Yoshikawa M, Kanda S et al. Potential use of embryonic stem cells for the treatment of mouse parkinsonian models: Improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. STEM CELLS 2003;21:171-180.
51. Ben-Hur T, Idelson M, Khaner H et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. STEM CELLS 2004;22:1246-1255.
52. Parish CL, Parisi S, Persico MG et al. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease. STEM CELLS 2005;23:471-476.
53. Fukuda H, Takahashi J, Watanabe K et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. STEM CELLS 2006;24:763-771.
54. Backlund EO, Granberg PO, Hamberger B et al. Transplantation of adrenal medullary tissue to striatum in parkinsonism. First Clinical Trials J Neurosurg 1985;62:169-173.
55. Drucker-Colin R, Madrazo I, Ostrosky-Solis F et al. Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients. Prog Brain Res 1988;78:567-574.
56. Olanow CW, Koller W, Goetz CG et al. Autologous transplantation of adrenal medulla in Parkinson's disease: 18-month results. Arch Neurol 1990;47:1286-1289.
57. Quinn NP. The clinical application of cell grafting techniques in patients with Parkinson's disease. Prog Brain Res 1990;82:619-625.
58. Espejo EF, Gonzalez-Albo MC, Moraes JP et al. Functional regeneration in a rat Parkinson's model after intrastriatal grafts of glial cell line-derived neurotrophic factor and transforming growth factor beta1-expressing extra-adrenal chromaffin cells of the Zuckerkandl's organ. J Neurosci 2001;21:9888-9895.
59. Drucker-Colin R, Verdugo-Diaz L, Morgado-Valle C et al. Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient: A preliminary report. Arch Med Res 1999;30:33-39.
60. Arjona V, Minguez-Castellanos A, Montoro RJ et al. Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery 2003;53:321-328, discussion 328-330.
61. Toledo-Aral JJ, Mendez-Ferrer S, Pardal R et al. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 2003;23:141-148.